Cargando…
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patients with advanced-stage cancer. In particular, recombinant vaccinia viruses (VV) hold great promise as interventional agents. In this article, we first summarize...
Autores principales: | Guo, Zong Sheng, Lu, Binfeng, Guo, Zongbi, Giehl, Esther, Feist, Mathilde, Dai, Enyong, Liu, Weilin, Storkus, Walter J., He, Yukai, Liu, Zuqiang, Bartlett, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325819/ https://www.ncbi.nlm.nih.gov/pubmed/30626434 http://dx.doi.org/10.1186/s40425-018-0495-7 |
Ejemplares similares
-
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
por: Guo, Zong Sheng, et al.
Publicado: (2017) -
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
por: Yang, Min, et al.
Publicado: (2021) -
Oncolytic viruses as therapeutic cancer vaccines
por: Bartlett, David L, et al.
Publicado: (2013) -
In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
por: Liu, Weilin, et al.
Publicado: (2020) -
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
por: Ge, Yan, et al.
Publicado: (2020)